| Literature DB >> 21861917 |
Bochra Gargouri1, Riadh Ben Mansour, Fatma Ben Abdallah, Abdelfetteh Elfekih, Saloua Lassoued, Hamden Khaled.
Abstract
BACKGROUND: The aim of this study is to investigate the effect of quercetin in alleviating the cytotoxic effects of Dimethoate in human peripheral blood lymphocytes.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21861917 PMCID: PMC3179742 DOI: 10.1186/1476-511X-10-149
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Changes in MDA levels of human lymphocytes incubated with different concentrations of Dimethoate (0, 40, 60,and 100 mM), quercetin (20 μg/ml)
| Experimental Groups | MDA mg/mg proteins |
|---|---|
| Control | 2.03 ± 0.1 |
| Quercetin (20 μg/ml) | 2.67 ± 0.71# |
| Dim (40 mM) | 3.62 ± 0.22* |
| Dim (40 mM)+ Quercetin (20 μg/ml) | 2.99 ± 0.15# |
| Dim (60 mM) | 4.51 ± 0.44* |
| Dim (60 mM)+ Quercetin (20 μg/ml) | 3.83 ± 0.31# |
| Dim (100 mM) | 5.92 ± 0.17* |
| Dim (100 mM)+ Quercetin (20 μg/ml) | 4.72 ± 0.34# |
The values are expressed as means ± SD; n = 20; controls are lymphocytes without Dimethoate, lymphocytes incubated with quercetin (20 μg/ml). # p < 0.05, compared with treatments without quercetin (20 μg/ml), compared with controls (lymphocytes without Dimethoate).
Changes in thiol (SH) levels of human lymphocytes incubated with different concentrations of Dimethoate (0, 40, 60 and 100 mM), quercetin (20 μg/ml)
| Experimental Groups | SH level mg/mg proteins |
|---|---|
| Control | 4.33 ± 0.1 |
| Quercetin (20 μg/ml) | 4.31 ± 0.1# |
| Dim (40 mM) | 2.53 ± 0.32* |
| Dim (40 mM)+ Quercetin (20 μg/ml) | 3.39 ± 0.55# |
| Dim (60 mM) | 5.67 ± 0.2* |
| Dim (60 mM)+ Quercetin (20 μg/ml) | 4.71 ± 0.3# |
| Dim (100 mM) | 6.81 ± 0.12* |
| Dim (100 mM)+ Quercetin (20 μg/ml) | 5.41 ± 0.31# |
The values are expressed as means ± SD; n = 20; controls are lymphocytes without Dimethoate, lymphocytes incubated with quercetin (20 μg/ml). # p < 0.05, compared with treatments without quercetin (20 μg/ml), compared with controls (lymphocytes without Dimethoate).
Changes in SOD activity of human lymphocytes incubated with different concentrations of Dimethoate (0, 40, 60, and 100 mM), quercetin (20 μg/ml)
| Experimental Groups | SOD % inhibition |
|---|---|
| Control | 3.33 ± 0.33 |
| Quercetin (20 μg/ml) | 3.33 ± 0.3# |
| Dim (40 mM) | 33.33 ± 0.21* |
| Dim (40 mM)+ Quercetin (20 μg/ml) | 15.59 ± 0.11# |
| Dim (60 mM) | 36.66 ± 0.23* |
| Dim (60 mM)+ Quercetin (20 μg/ml) | 24.00 ± 0.33# |
| Dim (100 mM) | 44.44 ± 0.44* |
| Dim (100 mM)+ Quercetin (20 μg/ml) | 33.33 ± 0.12# |
The values are expressed as means ± SD; n = 20; controls are lymphocytes without Dimethoate, lymphocytes incubated with quercetin (20 μg/ml) # p < 0.05, compared with treatments with quercetin (20 μg/ml). * p < 0.05, compared with controls (lymphocytes without Dimethoate).
Changes in CAT activity of human lymphocytes incubated with different concentrations of Dimethoate (0, 40, 60, and 100 mM), quercetin (20 μg/ml)
| Experimental Groups | CAT U/ml |
|---|---|
| Control | 366.44 ± 0.34 |
| Quercetin (20 μg/ml) | 360.00 ± 0.41# |
| Dim (40 mM) | 489.99 ± 0.21* |
| Dim (40 mM)+ Quercetin (20 μg/ml) | 396.98 ± 0.1# |
| Dim (60 mM) | 531.11 ± 0.4* |
| Dim (60 mM)+ Quercetin (20 μg/ml) | 461.51 ± 0.1# |
| Dim (100 mM) | 669.19 ± 0.01* |
| Dim (100 mM)+ Quercetin (20 μg/ml) | 570.12 ± 0.27# |
The values are expressed as means ± SD; n = 20; controls are lymphocytes without Dimethoate, lymphocytes incubated with quercetin (20 μg/ml) # p < 0.05, compared with treatments with quercetin (20 μg/ml). * p < 0.05, compared with controls (lymphocytes without Dimethoate).